ArticleJournal of molecular neuroscience : MN2026
Docosahexaenoic Acid Modulates Autophagy and Confers Neuronal Resilience under Hypoxia-Reoxygenation Stress.
Article in Journal of molecular neuroscience : MN, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hypoxia dramatically worsens neuronal death after injuries and strokes, as neurons rely heavily on oxidative phosphorylation for energy. This study investigated the effects of docosahexaenoic acid (DHA) in reducing cell death in nerve cells. Neuron-like cells, nerve growth factor-differentiated PC12 (NGFDPC12) cell cultures, with or without DHA pretreatment, were exposed to hypoxic conditions (0.5% O₂) for 12 to 48 h, followed by reoxygenation. Results showed that hypoxia caused a significant increase in the stress-response gene HIF-1α, with mRNA levels rising 5.47- and 6-fold at 24 and 48 h, respectively, compared to normoxic controls. Similarly, the pro-apoptotic gene BNIP3 was elevated 3.37- and 2.9-fold at the same time points. After 24 h of hypoxia, cells showed significant reactive oxygen species (ROS) buildup and displayed apoptotic features. The expression of fatty acid-binding protein 5 (FABP5), which is involved in responding to oxidative stress, also increased under hypoxic conditions. Treatment with DHA or rapamycin significantly improved cell viability after hypoxic exposure. To determine whether DHA protects by activating autophagy, we measured the expression of critical autophagy-related genes Atg5, Atg7, and Atg12. Hypoxia suppressed Atg5 and Atg7 expression; however, DHA restored and markedly increased the levels of Atg5, Atg7, and Atg12 beyond those in normoxic conditions. Immunoblot analysis supported these findings, showing higher levels of phosphorylated Beclin-1 and conjugated LC3, two key autophagy markers. These findings support our prior research, suggesting that DHA’s neuroprotective effects during hypoxia may involve the activation of autophagy pathways, highlighting its potential as a therapeutic strategy.Impact StatementThis study reveals that docosahexaenoic acid (DHA), an omega-3 fatty acid abundant in the brain, enhances neuronal resilience to hypoxia–reoxygenation injury by restoring autophagy function and limiting oxidative stress. These findings uncover a previously underappreciated role for DHA as a modulator of redox-sensitive autophagy pathways and suggest potential therapeutic strategies for ischemic and metabolic neurodegenerative disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.